Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Chairman operating in the Pharmaceutical space. If you think a Chairman is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Graham Richards
Chairman of Proteorex Therapeutics Inc.
Follow Graham Richards:
About : Expanding horizons to find cures
Dr Bruce Roser
Chairman & CSO of Stablepharma Ltd
Dr Bruce Roser MB BS, PhD – Chairman & Founder. Discovered the preservation properties of the resurrection plant. A distinguished international career in biomedical research with 108 refereed papers and 49 patents.
Follow Dr Bruce Roser:
About Stablepharma Ltd: An innovative Biotech, developing a wide range of reformulated thermostable and fridge free StablevaX vaccines
Alistair Wickens
Chairman of Health Hub
Follow Alistair Wickens:
About Health Hub: Innovative online sales platform that allows users to purchase drugs with real-time price solutions and transparent pricing
Barry Clare
Chairman of Evgen Pharma
Follow Barry Clare:
About Clarat: Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions
Alan Taylor
Executive Chairman of Clarity Pharmaceuticals
Dr Alan Taylor has a background as a scientist, investment banker, entrepreneur and investor. Alan is currently very active in the Australian start-up area, investing in, advising and taking an active role within a number of early stage companies. Alan is currently the Executive Chairman at Clarity Pharmaceuticals, a company focused on developing radiopharmaceuticals for the treatment of cancer and other diseases. Alan is also the Chairman and co-founder of Mizzen Group Pty Ltd, a new technology start-up company. Alan is passionate about the commercialisation of Australian science and technologies, either in general technology or the life sciences. Alan has approximately 10 years of investment banking experience, and was until recently an Executive Director and shareholder of Inteq Limited, a boutique Australian investment bank, where he remains on the Board of Directors. Alan has significant experience in capital raisings, mergers and acquisitions, and general corporate advisory. At Inteq, Alan was involved in some of the largest ever medical device transactions in Australia. Alan completed an undergraduate degree in Applied Science at the University of Sydney, where he finished first in his year and won the prestigious University Medal. He completed his Ph.D. in Medicine at the Garvan Institute of Medical Research.
Follow Alan Taylor:
About Clarity Pharmaceuticals: Clarity Pharmaceuticals is a personalized medicine company focused on the treatment of serious disease.
